Missouri Partners with Impruvon to Automate Medication Management

The partnership integrates Impruvon’s Health Risk Screening Tool with its eMAR system to automate complex diagnosis and medication inputs. By streamlining these workflows, the state seeks to prevent unnecessary hospitalizations and maintain the health of at-risk populations. Justin Amoyal, CEO of Impruvon, noted that the move positions Missouri as a leader in equipping residential home and community-based service providers with essential digital infrastructure.

Brit Keller, the company's Chief Customer Officer, emphasized that the rollout prioritizes staff retention alongside clinical compliance. As the implementation proceeds, over 500 residential, day, and community-based sites will gain access to the platform. Impruvon plans to showcase these capabilities to providers at the upcoming Starling Conference in Branson, scheduled for November 17–18, 2026.